J.P. Soulillou

Affiliations

INSERM Unit 211 ( T Lymphocytes), Nantes, France

INSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

and Immunotech, Marseille-Luminy, France

a,b,c,d ∙

B. Le Mauff

Affiliations

INSERM Unit 211 ( T Lymphocytes), Nantes, France

INSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

and Immunotech, Marseille-Luminy, France

a,b,c,d ∙

D. Olive

Affiliations

INSERM Unit 211 ( T Lymphocytes), Nantes, France

INSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

and Immunotech, Marseille-Luminy, France

a,b,c,d ∙

M. Delaage

Affiliations

INSERM Unit 211 ( T Lymphocytes), Nantes, France

INSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

and Immunotech, Marseille-Luminy, France

a,b,c,d ∙

P. Peyronnet

Affiliations

INSERM Unit 211 ( T Lymphocytes), Nantes, France

INSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

and Immunotech, Marseille-Luminy, France

a,b,c,d ∙

M. Hourmant

Affiliations

INSERM Unit 211 ( T Lymphocytes), Nantes, France

INSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

and Immunotech, Marseille-Luminy, France

a,b,c,d ∙

C. Mawas

Affiliations

INSERM Unit 211 ( T Lymphocytes), Nantes, France

INSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

and Immunotech, Marseille-Luminy, France

a,b,c,d ∙

M. Hirn

Affiliations

INSERM Unit 211 ( T Lymphocytes), Nantes, France

INSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

and Immunotech, Marseille-Luminy, France

a,b,c,d ∙

Y. Jacques

Affiliations

INSERM Unit 211 ( T Lymphocytes), Nantes, France

INSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

and Immunotech, Marseille-Luminy, France

a,b,c,d ∙ et al. Show more

Affiliations & Notes

aINSERM Unit 211 ( T Lymphocytes), Nantes, France

bINSERM Unit 119 (Experimental Oncology and Therapy), Cancérologie et Thérapeutique Expérimentales, Marseille, France

cNephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France

dand Immunotech, Marseille-Luminy, France

Article Info

Publication History:

Published June 13, 1987

Linked Articles (0)